Background The purpose of the study was to investigate the relation of lipoprotein(a) and serum lipid parameters to restenosis after percutaneous transluminal coronary angioplasty (PTCA) and to assess the association of these same biochemical markers to coronary artery disease (CAD) in individuals with angiographically defined normal and diseased coronary arteries.
Background The purpose of the study was to investigate the relation of lipoprotein(a) and serum lipid parameters to restenosis after percutaneous transluminal coronary angioplasty (PTCA) and to assess the association of these same biochemical markers to coronary artery disease (CAD) in individuals with angiographically defined normal and diseased coronary arteries.
Methods and Results Sixty-two patients with successful PTCA had follow-up angiography at 35 + 10 weeks. Restenosis occurred in 21 male patients (46%) and 6 female patients (38%). Elevated apolipoprotein B (P<.01) and decreased high-density lipoprotein-2 cholesterol (P<.02) were found to be independently associated with restenosis after angioplasty, whereas lipoprotein(a) was not.
T he role of percutaneous transluminal coronary angioplasty (PTCA) in the treatment of myocardial ischemia is well established. Although the primary success rate is very high (>90%), restenosis of the treated artery remains the major long-term complication, occurring in 30% to 40% of lesions.12 Newer imaging techniques and a variety of pharmacological agents have failed to reduce the incidence of restenosis. 3, 4 The association between conventional blood lipid parameters and apolipoproteins in the development and progression of coronary artery disease is now widely accepted.5-9 However, the relevance of these blood lipids with respect to vascular restenosis is conflicting. 10 Lp(a) concentrations in serum and arterial wall plaques are correlated. 29 The role of serum Lp(a) concentrations in restenosis after coronary angioplasty remains unclear. 10 Decreased concentrations of total high-density lipoprotein cholesterol (HDL-C), HDL2, and HDL3 cholesterol are associated with increased risk of coronary heart disease,30 but the association between the HDL-C subfractions and restenosis has not yet been established.
We undertook this study to evaluate prospectively the association between Lp(a), HDL-C subsets, blood lipids, and restenosis after PTCA. We also examined the relation of these same parameters to the presence of CAD in an angiographically defined disease and control population.
Patients
One hundred five consenting patients presenting consecutively for PTCA were recruited for the study. Patients with an acute myocardial infarction (n=20) of <3 months before the procedure were excluded because of the known confounding effects of myocardial infarction on serum lipid concentrations. Angioplasty was unsuccessful in 19 patients. After a 14-hour overnight fast, 20 mL of clotted blood was obtained before the procedure.
All patients (N=66) with a successful angioplasty (reduction of diameter stenosis to <50% without major in-hospital complications) were scheduled to have a restudy angiogram performed 6 
Biochemical Methods
Plasma total cholesterol and triglycerides were measured using automated enzymatic procedures (CHOD-PAP, Boehringer-Mannheim and Triglycerides Enzymatiques PAP 150, bioMerieux) on a Centrifichem 400 analyzer. Plasma total HDL, HDL2, and HDL3 cholesterol were determined after selective precipitation with polyethylene glycol (Quantolip HDL (HDL2/HDL3), Immuno Diagnostics, Vienna, Austria). LDL cholesterol (LDL-C) was measured after selective precipitation with dextran sulfate (Quantolip-LDL, Immuno Diagnostics). Apo Al and B (Apo Al, Apo B) concentrations were analyzed using an automated immunoturbidimetric method.3' Antibodies and calibrators were obtained from the International Immunology Corporation, Murietta, Calif. Lp(a) concentrations were assessed using an ELISA technique (TintElize Lp(a), Biopool). Precinorm L (Boehringer-Mannheim) and Lp(a) reference standard (Immuno Diagnostics) were used as control materials.
Plasma total cholesterol, triglycerides, HDL, HDL2, HDL3, and LDL cholesterol were analyzed on the day of venipuncture. Serum for apo Al and B and Lp(a) was stored at -20°C until analysis. Mean storage time of samples for apo Al and B and Lp(a) analysis was 43.6 days. All patient and control samples were analyzed in duplicate with appropriate quality control procedures operating. The ratios of total cholesterol to total HDL-C, total HDL to LDL cholesterol, and apo Al to B were also examined.
Statistical Methods
All continuous variables were compared using twosample t tests, except Lp(a), which has a skewed distribution, so a Wilcoxon test was used. Categorical variables were compared using the x statistic and Fisher exact tests. Multivariate analysis was done using the logistic regression model. The analysis was performed using the STATA statistical package732
Results

Restenosis Study
Of the 62 patients (46 male, 16 female) who underwent PTCA and had a follow-up angiogram at 35±10 weeks, 21 male patients (46%) and 6 female patients (38%) restenosed. An exploratory univariate analysis stratified by sex was done to identify risk factors that may be associated with restenosis (Table 1) . Only one subject was on HRT, and since inclusion of this case had negligible effect on the results, she was included in the final analysis. Female patients who restenosed differed significantly from those who did not with respect to HDL2-C, triglycerides, apo B, and apo Al to B ratio. For male patients, a significant difference was found only for the percent occlusion of the treated site before angioplasty.
A multivariate analysis that adjusted for age and sex indicated that higher levels of apolipoprotein B and lower levels of HDL2-C are independently associated with restenosis. The odds ratios and associated confidence intervals are presented in Table 2 .
Of the 33 patients who had a restudy blood sample taken, restenosis occurred in 16. No significant difference was found in any of the biochemical markers between the restenosed and nonrestenosed groups in blood samples taken at restudy, neither was there a significant change in these markers from baseline in relation to restenosis. However, a marginal change in HDL3 was detected (restenosis group, -0.16 mmol/L. nonrestenosis group, +0.11 mmol/L; one-sided P value <.06). The correlation coefficient for Lp(a) at baseline and restudy was .944.
Coronary Artery Disease Versus Control Study
Univariate analysis, stratified by sex, was performed to compare the measured risk factors in the patients with documented CAD and control subjects (Table 3 ). All the female cases were postmenopausal with one case on HRT, while four of the control subjects were premenopausal. The data were analyzed with and without these subjects, but we found that their inclusion had negligible effect on the study results and so they were included in the final analysis. Both male and female cases and control subjects differ significantly with respect to age, smoking status, Lp(a), and apo B. In addition, female cases and control subjects differ significantly with respect to hypertension, total cholesterol. Lp(a) indicates lipoprotein(a); Chol, cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; and Apo, apolipoprotein.
Mean±SD is represented for all continuous variables except Lp(a), percent occlusion before and after angioplasty, and percent change in occlusion after angioplasty, for which the median and range are reported. *P<.05, tP<.01, *P<.001, §P=.1.
LDL-C, and HDL3-C, whereas for male cases, there were significant differences for apo Al and apo Al/B ratio.
A multivariate logistic regression analysis demonstrated that Lp(a) and apo Al to B ratio are independently associated with CAD, adjusted for age, sex, and smoking status. The odds ratios and associated confidence intervals are presented in Table 4 .
Discussion
Our study examined prospectively the relation between serum Lp(a), lipids, apolipoproteins, HDL-C subsets, nonlipid risk factors with restenosis after PTCA and, retrospectively, the association between these same Low concentrations of HDL2-C and HDL3-C are associated with premature coronary artery disease.30,37 To our knowledge, no information exists on the association of HDL-C subfractions with restenosis. Shah and Amin36 did find a significant association with low total HDL-C concentrations and restenosis after angioplasty. Our study indicates that elevated apo B and decreased HDL2-C are independently associated with restenosis. While acknowledging a high angiographic follow-up, we appreciate that the sample size is relatively small, and a larger study would be required to support these findings.
Coronary Artery Disease Versus Control Study
In this part of the study, we demonstrated a significant independent association between serum Lp(a) concentrations, apo Al to B ratio, and the presence of CAD. Similar associations with respect to Lp(a) were found in other studies15,41; however, Hearn et a141 found no association with respect to apo Al to B ratio. One prospective study established apo(a) as a significant independent risk factor but found apo Al a stronger negative independent risk factor with respect to CAD in men. 42 Armstrong et a143 studied the association between Lp(a) and other risk factors for predicting CAD. Lp(a) was found to increase the odds ratio to 1.47 at the lowest tertile of LDL. However, at the middle or upper tertile, the odds ratio increased substantially to 3.86 and 4.73, respectively. Thus, whereas Lp(a) exerts an effect at low LDL levels, its effect is greatly augmented at higher LDL levels. Armstrong et al suggest that a possible reason for lack of atherogenicity of Lp(a) in the black population might be due to correspondingly low LDL-C levels. Patients with familial hypercholesterolemia and CAD have elevated Lp(a) concentrations that are independent of other risk factors. 13 It has been suggested that apo(a) concentration could be substituted for parental history in a logistic regression model.12 Serum Lp(a) levels are largely determined by alleles at the hypervariable apo(a) gene locus, which gives rise to multiple protein isoforms in blood. The smaller-molecular-weight isoforms are associated with elevated plasma concentrations of Lp(a). 44 The presence of the smaller-molecular-weight isoforms in a Chinese population was significantly more frequent in patients with CAD than in control subjects,45 supporting the hypothesis that alleles at the apo(a) locus determine the risk for CAD through their effect on serum Lp(a) levels, thus suggesting a role for serum Lp(a) as a primary genetic risk factor. Using univariate analysis stratified by sex, we found serum Lp(a), apo B, age, and smoking status to be significantly different between cases and control subjects in both male and female patients. As might be expected, women with disease were older than their male counterparts and, interestingly, they had higher Lp Lp(a) concentrations, further analysis of the data was undertaken excluding these five female subjects. This did not alter the outcome. All of the female subjects in the restenosis study were postmenopausal, so our results for women can only be generalized to those who are postmenopausal.
There is evidence that the serum level of the apolipoproteins Al and B and their ratios are better discriminators of CAD than conventional plasma lipids and lipoproteins. 51 Using a multivariate analysis, we demonstrated that the apo Al to B ratio was an independent predictor of CAD but was not as strong as Lp(a). Among the nonlipid risk factors, age, male sex, and smoking were also found to be independently associated with CAD, with odds ratios of 1.07, 3.96, and 4.87, respectively. Lp(a) concentration correlated only weakly with total cholesterol and LDL, whereas no association was found with the severity of disease.
In summary, Lp(a) was not found to be associated with restenosis after PTCA but was highly correlated with the presence of CAD. Elevated levels of apo B and reduced HDL2-C are independently associated with restenosis, and strategies aimed at their modification may result in reducing the Achilles' heel of this procedure.
